INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 285 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,132,998 | +107.4% | 112,650 | +77.4% | 0.99% | +106.0% |
| Q1 2023 | $3,439,067 | -43.3% | 63,510 | -44.5% | 0.48% | -42.0% |
| Q4 2022 | $6,061,139 | +54.0% | 114,534 | +35.4% | 0.83% | +57.4% |
| Q3 2022 | $3,936,000 | -79.0% | 84,584 | -74.2% | 0.53% | -79.3% |
| Q2 2022 | $18,716,000 | +9.9% | 327,894 | +17.8% | 2.54% | +32.9% |
| Q1 2022 | $17,035,000 | +3478.8% | 278,395 | +2170.8% | 1.91% | +166.4% |
| Q2 2016 | $476,000 | – | 12,260 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |